FAQ

Primary focal hyperhidrosis

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2018
012320002018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Needle-Free Administration of Botulinum Toxin for Primary Focal Hyperhidrosis: Initial Experience
Local intradermal injections of botulinum toxin (BTX) effectively provide symptom relief of primary focal hyperhidrosis (PFHH… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Overexpression of AQP5 Was Detected in Axillary Sweat Glands of Primary Focal Hyperhidrosis Patients.
BACKGROUND The expression of aquaporin 5 (AQP5) in human axillary sweat glands has never been studied so far. OBJECTIVE To… (More)
Is this relevant?
2016
2016
Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers.
BACKGROUND/OBJECTIVES Oral anticholinergic drugs, such as oxybutynin, are often used in the treatment of hyperhidrosis, but few… (More)
Is this relevant?
Review
2013
Review
2013
Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis.
Primary hyperhidrosis is a disorder of excessive, bilateral and relatively symmetrical sweating occurring in the palms, soles and… (More)
Is this relevant?
2013
2013
Suture boots: an aid for the injection of onabotulinum toxin a for primary focal hyperhidrosis.
Primary focal hyperhidrosis is a difficult problem for adults, children, and adolescents, causing significant impairment in… (More)
Is this relevant?
2011
2011
Primary focal hyperhidrosis in a new family not linked to known loci.
BACKGROUND Primary focal hyperhidrosis (PFH) is a disabling disorder. A first locus has been mapped in families with only palmar… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee.
BACKGROUND Hyperhidrosis can have profound effects on a patient's quality of life. Current treatment guidelines ignore disease… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
BACKGROUND Primary focal hyperhidrosis (PFH) is defined as excessive sweating typically localized to specific body areas such as… (More)
Is this relevant?
2001
2001
Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
Focal hyperhidrosis is a condition that may disturb emotional, social and professional life. Treatment options for severe cases… (More)
Is this relevant?
2000
2000
Cardiac autonomic function in patients suffering from primary focal hyperhidrosis.
Cardiac autonomic function in patients (n = 63) with primary focal hyperhidrosis and healthy controls (n = 28) was investigated… (More)
Is this relevant?